FCHV-HTN Implementation Trial in Nepal

Recruiting N/A Interventional Study
Hypertension
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
30 and older
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
3,572 (estimated)
Sponsor
Yale University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this hybrid type III study incorporating a cluster-randomized trial is to assess the effect of a community health worker-led hypertension prevention and control program (CHPC) on the implementation outcomes and clinical outcomes among patient with hypertension in central Nepal. The main questions it aims to answer are: 1\. What is the level of implementation outcomes, including reach,…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: -High blood pressure (BP) of 140/90 mmHg or higher. Exclusion Criteria: * Severe illness requiring bed rest * Pregnant women, due to their special health needs
Contacts

Donna Spiegelman, ScD

6178355119

donna.spiegelman@yale.edu

CONTACT

Eleni Mersiadis

eleni.mersiadis@yale.edu

CONTACT